Search clinical trials for: DZD9008 and intraconazole

Total 270830 results

Dizal (Jiangsu) Pharmaceutical Co., Ltd.
PPD Development, L.P.

Recruiting

DZD9008 PK Study in Hepatic Impairment Subjects

Hepatic Impairment

United States
Peking Union Medical College Hospital
Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Recruiting

Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15) (WU-KONG15)

Non Small Cell Lung Cancer

China
Dizal Pharmaceuticals

Completed

Pharmacokinetic and Mass Balance Study of Oral-Administrated [14C]-DZD9008 in Healthy Male Subjects

Healthy Volunteers

United States
Dizal Pharmaceuticals

Recruiting

Assessing an Oral EGFR Inhibitor, DZD9008 in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)

Non-Small Cell Lung Cancer

Spain, Korea, Republic of, United States, Taiwan, France, Italy, Malaysia, Australia, Japan
Dizal Pharmaceuticals

Active, not recruiting

DZD9008 in Pretreated Lung Cancer Patients With EGFR Exon20 Insertion Mutation

Non-Small Cell Lung Cancer

China
Dizal Pharmaceuticals

Completed

Assessing the Safety, Tolerability and Pharmacokinetics(PK) of DZD9008 and the Effect of Low-fat Meal on PK of DZD9008 in Healthy Adult Participants

Healthy Volunteers

United States
Dizal Pharmaceuticals

Recruiting

A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21)

Non-small Cell Lung Cancer

China
Dizal Pharmaceuticals

Suspended

Assessing an Oral Bruton Tyrosine Kinase Inhibitor, DZD9008 in Patients Who Have Non-Hodgkin B-cell Lymphoma (WU-KONG3)

Non-Hodgkin's B-cell Lymphoma

China
Dizal Pharmaceuticals

Completed

Drug-drug Interactions Between DZD9008 and Itraconazole/Carbamazepine

Healthy Subjects

United States
University of Maryland, Baltimore

Completed

Itraconazole Oral Absorption

Fungal Infection

United States
Dizal Pharmaceuticals

Recruiting

A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Dizal Pharmaceuticals

Recruiting

DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29)

Non-small Cell Lung Cancer

China
University of Alabama at Birmingham
Washington University School of Medicine; University of California, Davis

Completed

Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole (MSG15)

Invasive Fungal Infections

United States, Panama
Johns Hopkins University
Memorial Sloan Kettering Cancer Center

Completed

A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy

Prostate Cancer

United States
Sara Botros

Completed

Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel

Tinea Versicolor

Egypt
Pulmatrix Inc.

Completed

Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults With Asthma

Asthma

United Kingdom
University of Kansas Medical Center
University of Texas, Southwestern Medical Center at Dallas

Recruiting

Itraconazole to Prevent Recurrent Barrett's Esophagus

Barrett Oesophagitis With Dysplasia

United States
Halcygen Pharmaceuticals Limited

Completed

Study Comparing SUBA™-Itraconazole With SPORANOX® (Itraconazole) in the Treatment of Onychomycosis

Onychomycosis

United States
H. Lundbeck A/S

Completed

Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women

Cytochrome P450 Interaction

United Kingdom, United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.

Onychomycosis

United States, South Africa, Canada, Dominican Republic, Ecuador, Honduras, Panama
Sidney Kimmel Comprehensive Cancer Center at Johns...

Terminated

A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC. (NA_00067809)

Non-small Cell Lung Cancer Metastatic

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

Effect of Itraconazole on the Pharmacokinetics of Apatinib

Neoplasms

China
Pfizer

Completed

Effect Of Itraconazole On The Pharmacokinetics Of Palbociclib

Healthy

United States
Postgraduate Institute of Medical Education and...

Recruiting

Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome (GLITZ)

Allergic Bronchopulmonary Aspergillosis | Chronic Pulmonary Aspergillosis

India
Hangzhou Cancer Hospital

Recruiting

CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer

Esophageal Diseases | Esophageal Squamous Cell Carcinoma | Esophageal Neoplasm

China
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Interaction Between ASP1707 and Itraconazole in Healthy Female Subjects

Healthy Subjects | Pharmacokinetics | DDI (Drug-Drug Interaction)

Germany
National Institute of Allergy and Infectious Diseases...

Completed

Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease

Mycoses

United States
Samsung Medical Center

Completed

Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

Mycoses | Brain Tumor | Neuroblastoma | Retinoblastoma | Wilms Tumor

Korea, Republic of
National Center for Research Resources (NCRR)
National Institute of Allergy and Infectious Diseases (NIAID); University of...

Completed

Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis

Histoplasmosis | Sporotrichosis | Blastomycosis
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Itraconazole Effect Study of SHR2554 on Healthy Chinese Adult Subjects

Healthy Adult Subjects

China
Indiana University

Completed

A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer

Breast Neoplasms | Neoplasm Metastasis

United States
Mayne Pharma International Pty Ltd

Completed

Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis

Neutropenia

Australia
Pfizer

Completed

A Study To Estimate The Effects Of Itraconazole On Pharmacokinetics Of Pf-06649751 In Healthy Adult Subjects

Healthy

Belgium
Hoffmann-La Roche

Completed

A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RG1662 in Healthy Subjects

Healthy Patient Study

United Kingdom
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood

Healthy

Germany
HedgePath Pharmaceuticals, Inc.

Completed

Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)

Basal Cell Carcinoma in Basal Cell Nevus Syndrome

United States
Jonsson Comprehensive Cancer Center

Completed

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Cancer

United States
Hospital de Clinicas de Porto Alegre

Unknown

Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin.

Basal Cell Carcinoma | Hedgehog Pathway

Brazil
Mayne Pharma International Pty Ltd

Completed

Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg

Neutropenia

Australia
Seoul National University Hospital

Completed

Pharmacokinetics of Itraconazole in Pediatric Cancer Patients

Pediatric, Cancer

Korea, Republic of
Pulmatrix Inc.

Terminated

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA

ABPA

Australia, United States, United Kingdom, France
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study to Evaluate the Effect of Itraconazole on Pharmacokinetics (PK) of SHR8554 in Healthy Adult Subjects

Healthy

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Study on the Pharmacokinetic Effect of Itraconazole on SHR0302 Tablets in Healthy Subjects

Rheumatoid Arthritis

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Effect of Itraconazole on the Pharmacokinetics of SHR6390 in Healthy Subjects

Healthy Subjects

China
Boehringer Ingelheim

Completed

This Study in Healthy Men Tests How Itraconazole Influences the Amount of BI 1015550 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

Interaction of BI 691751 With Itraconazole

Healthy

Germany
Guangzhou General Hospital of Guangzhou Military...
First Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern... and other collaborators

Unknown

Long-term Versus Short-term Sequential Therapy (Intravenous Itraconazole Followed by Oral Solution) of Itraconazole as Primary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation

Hematological Diseases | Allogeneic Stem Cell Transplantation

China
Jiangsu HengRui Medicine Co., Ltd.
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Completed

A Phase I Study of SHR1459 in Healthy Subjects

Health, Subjective

China
George R Thompson
Mayne Pharma International Pty Ltd

Withdrawn

SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole (SITRIS)

Coccidioidomycosis | Valley Fever

United States
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects

Healthy Volunteers | Pharmacokinetics of ASP3700

United Kingdom

3

Subscribe